Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05977907 |
| Title | Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). (KIEO) |
| Acronym | KIEO |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sibley Memorial Hospital | Washington D.C. | District of Columbia | 20016 | United States | Details | |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | United States | Details | |
| Johns Hopkins University | Baltimore | Maryland | 21287 | United States | Details | |
| Providence Cancer Institute | Portland | Oregon | 97213 | United States | Details | |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | United States | Details |